GSK to unveil clinical trial results on several drugs in development

02/10/2005 | Wall Street Journal, The

GlaxoSmithKline plans to unveil today the results of clinical trials on several drugs, including one to treat diabetes, one of more than a dozen drugs the company has under development. The company has been overhauling its research and development division, and the progress on 13 drugs in Phase III trials out of about 90 products GSK is developing could be a positive response to investors who have been clamoring for results.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI